newsfilter
← Latest News
GlobeNewswire·

Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business

Initiates Strategic Repositioning to Focus on Company's Core RNA Delivery Technology Altamira Therapeutics retains 49% in Altamira Medica AG, and secures 25% of future licensing revenue Hamilton,